{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T18:00:22Z","timestamp":1773511222455,"version":"3.50.1"},"reference-count":45,"publisher":"Scientific Foundation Spiroski (publications)","issue":"4","license":[{"start":{"date-parts":[[2015,11,14]],"date-time":"2015-11-14T00:00:00Z","timestamp":1447459200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Open Access Maced J Med Sci"],"abstract":"<jats:p>BACKGROUND: While dosing theophylline in asthmatics, we should consider that a lot of medicines, substances, conditions and diseases affect the clearance of theophylline, such as smoking, macrolide antibiotics, barbiturates, oral contraceptives, heart and liver insufficiency, alcohol, calcium-antagonists, pneumonia, viral infections, hypoxemia, etc.AIM: The aim of the study is to investigate the concentrations of theophylline during the day in smoking and nonsmoking patients with asthma.MATERIAL AND METHODS: We have estimated the concentrations of theophylline 6 times daily by the HPLC method (Keith Muir, J Chromatography) in 20 smoking and 20 nonsmoking asthmatic patients, who were treated with theophylline sustained-release tablets 175 mg twice daily.RESULTS: In the first group of 20 nonsmoking patients we obtained constant therapeutic and optimal concentrations of theophylline. In the second group of 20 smoking asthmatics the concentration of theophylline in plasma, in 8pm and 8am the next day was very low.CONCLUSION: Because in smokers we have increased clearance and the decreased half- life of theophylline, and in order to prevent the night time life-threatening attacks, it is necessary to recommend maximal doses of theophylline, especially in the evening. According to the study, dosage should be individualized in order to optimize the treatment based on the measurement of theophylline concentration in plasma.<\/jats:p>","DOI":"10.3889\/oamjms.2015.117","type":"journal-article","created":{"date-parts":[[2015,11,21]],"date-time":"2015-11-21T21:08:40Z","timestamp":1448140120000},"page":"672-675","source":"Crossref","is-referenced-by-count":4,"title":["Analysis of Plasma Concentrations of Theophylline in Smoking and Nonsmoking Patients with Asthma"],"prefix":"10.3889","volume":"3","author":[{"given":"Zlatica","family":"Goseva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelko","family":"Gjorcev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biserka","family":"Jovkovska Kaeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Jovanovska Janeva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Angelovska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"52292","published-online":{"date-parts":[[2015,11,14]]},"reference":[{"key":"15571","unstructured":"Global Initiative for Asthma (GINA), GINA Report 2015, Global Strategy for Asthma Management and Prevention, updated 2015."},{"key":"15572","doi-asserted-by":"crossref","unstructured":"Barnes PJ. Theophylline. Am J Respir Crit Care Med. 2013;188(8):901-6.","DOI":"10.1164\/rccm.201302-0388PP"},{"key":"15573","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.1164\/rccm.201302-0388PP","DOI":"10.1164\/rccm.201302-0388PP"},{"key":"15574","unstructured":"PMid:23672674"},{"key":"15575","doi-asserted-by":"crossref","unstructured":"Kawai M, Kato M. Theophylline for the treatment of bronchial asthma: Present status. Methods Find Exp Clin Pharmacol. 2000;22(5):309.","DOI":"10.1358\/mf.2000.22.5.796650"},{"key":"15576","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.1358\/mf.2000.22.5.796650","DOI":"10.1358\/mf.2000.22.5.796650"},{"key":"15577","unstructured":"PMid:11031732"},{"key":"15578","doi-asserted-by":"crossref","unstructured":"Tilley SL. Handbook of Experimental Pharmacology. Methylxanthines in Asthma, 2011:pp 439-456.","DOI":"10.1007\/978-3-642-13443-2_17"},{"key":"15579","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.1007\/978-3-642-13443-2_17","DOI":"10.1007\/978-3-642-13443-2_17"},{"key":"15580","unstructured":"Morf\u00c3\u00adn Maciel BM, Castillo Morf\u00c3\u00adn BM. Theophylline, a new look to an old drug. Rev Alerg Mex. 2010;57(4):112-22."},{"key":"15581","unstructured":"PMid:21255523"},{"key":"15582","doi-asserted-by":"crossref","unstructured":"Ito K, Lim S, Caramori G, Cosio B, Chung KF, Adcock IM, Barnes PJ. A molecular mechanism of action of theophylline: Induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci USA. 2002;99(13):8921-6.","DOI":"10.1073\/pnas.132556899"},{"key":"15583","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.1073\/pnas.132556899","DOI":"10.1073\/pnas.132556899"},{"key":"15584","unstructured":"PMid:12070353 PMCid:PMC124399"},{"key":"15585","doi-asserted-by":"crossref","unstructured":"Zevin S, Benowitz NL. Drug interactions with tobacco smoking. An update. Clin Pharmacokinet. 1999;36(6):425-38.","DOI":"10.2165\/00003088-199936060-00004"},{"key":"15586","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.2165\/00003088-199936060-00004","DOI":"10.2165\/00003088-199936060-00004"},{"key":"15587","unstructured":"PMid:10427467"},{"key":"15588","doi-asserted-by":"crossref","unstructured":"Thomson NC, Chaudhuri R, Livingston E. Asthma and cigarette smoking. European Respiratory Journal. 2004;24:822\u00e2\u20ac\u201c833.","DOI":"10.1183\/09031936.04.00039004"},{"key":"15589","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.1183\/09031936.04.00039004","DOI":"10.1183\/09031936.04.00039004"},{"key":"15590","unstructured":"PMid:15516679"},{"key":"15591","doi-asserted-by":"crossref","unstructured":"Muir KT, Jonkman JH, Tang DS, Kunitani M, Riegelman S. Simultaneous determination of theophylline and its major metabolites in urine by reversed-phase ion-pair high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications. 1980;221(1): 85-95.","DOI":"10.1016\/S0378-4347(00)81010-5"},{"key":"15592","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.1016\/S0378-4347(00)81010-5","DOI":"10.1016\/S0378-4347(00)81010-5"},{"key":"15593","doi-asserted-by":"crossref","unstructured":"Thomson NC. Smokers with asthma: what are the management options? Am J Respir Crit Care Med. 2007;175(8):749-50.","DOI":"10.1164\/rccm.200701-017ED"},{"key":"15594","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.1164\/rccm.200701-017ED","DOI":"10.1164\/rccm.200701-017ED"},{"key":"15595","unstructured":"PMid:17484086"},{"key":"15596","doi-asserted-by":"crossref","unstructured":"Chalmers GW, et al. Smoking and airway inflammation in patients with mild asthma. Chest. 2001;120(6):1917-22.","DOI":"10.1378\/chest.120.6.1917"},{"key":"15597","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.1378\/chest.120.6.1917","DOI":"10.1378\/chest.120.6.1917"},{"key":"15598","unstructured":"PMid:11742922"},{"key":"15599","doi-asserted-by":"crossref","unstructured":"Hylkema NM, Sterk PJ, De Boer WI, Postma DS. Tobacco use in relation to COPD and asthma. Eur Resp J. 2007: 29(3):438-445.","DOI":"10.1183\/09031936.00124506"},{"key":"15600","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.1183\/09031936.00124506","DOI":"10.1183\/09031936.00124506"},{"key":"15601","unstructured":"PMid:17329490"},{"key":"15602","doi-asserted-by":"crossref","unstructured":"Kroon LA. Drug interactions with smoking. Am J Health-Syst Pharm. 2007;64:1917-1921.","DOI":"10.2146\/ajhp060414"},{"key":"15603","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.2146\/ajhp060414","DOI":"10.2146\/ajhp060414"},{"key":"15604","unstructured":"PMid:17823102"},{"key":"15605","doi-asserted-by":"crossref","unstructured":"Thomson NC, Spears M. The influence of smoking on the treatment response in patients with asthma. Curr Opin Allergy Clin Immunol. 2005;5(1):57-63.","DOI":"10.1097\/00130832-200502000-00011"},{"key":"15606","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.1097\/00130832-200502000-00011","DOI":"10.1097\/00130832-200502000-00011"},{"key":"15607","doi-asserted-by":"crossref","unstructured":"Spears M, et al. Effect of low-dose theophylline plus beclometasone on lung function in smokers with asthma: a pilot study. Eur Resp J. 2009;33(5):1010-1017.","DOI":"10.1183\/09031936.00158208"},{"key":"15608","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.1183\/09031936.00158208","DOI":"10.1183\/09031936.00158208"},{"key":"15609","unstructured":"PMid:19196814"},{"key":"15610","doi-asserted-by":"crossref","unstructured":"Stapleton M, Howard-Thompson A, George Ch, Hoover MR, Self HT. Smoking and Asthma. J Am Board Fam Med. 2011;24:313-322.","DOI":"10.3122\/jabfm.2011.03.100180"},{"key":"15611","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.3122\/jabfm.2011.03.100180","DOI":"10.3122\/jabfm.2011.03.100180"},{"key":"15612","unstructured":"PMid:21551404"},{"key":"15613","doi-asserted-by":"crossref","unstructured":"An-Soo Jang, at al. The Impact of Smoking on Clinical and Therapeutic Effects in Asthmatics. J Korean Med Sci. 2009;24(2):209-214.","DOI":"10.3346\/jkms.2009.24.2.209"},{"key":"15614","doi-asserted-by":"crossref","unstructured":"http:\/\/dx.doi.org\/10.3346\/jkms.2009.24.2.209","DOI":"10.3346\/jkms.2009.24.2.209"},{"key":"15615","unstructured":"PMid:19399260 PMCid:PMC2672118"}],"container-title":["Open Access Macedonian Journal of Medical Sciences"],"original-title":[],"link":[{"URL":"https:\/\/oamjms.eu\/index.php\/mjms\/article\/download\/oamjms.2015.117\/579","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/oamjms.eu\/index.php\/mjms\/article\/download\/oamjms.2015.117\/625","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,30]],"date-time":"2021-05-30T23:00:29Z","timestamp":1622415629000},"score":1,"resource":{"primary":{"URL":"https:\/\/oamjms.eu\/index.php\/mjms\/article\/view\/oamjms.2015.117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,14]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,12,15]]}},"URL":"https:\/\/doi.org\/10.3889\/oamjms.2015.117","relation":{},"ISSN":["1857-9655"],"issn-type":[{"value":"1857-9655","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,14]]}}}